Beneficiaries list of Dystrogen Therapeutics

Beneficiaries of Dystrogen Therapeutics

Company age:
Age:
8 y. 2 m. 3 d.
Share capital:
Share capital:
171 886 PLN

Entries in the Central Register of Beneficial Owners shows that Dystrogen Therapeutics has 2 beneficiaries.

Krzysztof Siemionow
Holds 0.02% shares in a company with a total amount of 30 zł
Maria Siemionow
Holds 0.02% shares in a company with a total amount of 30 zł

A beneficiary is an individual or entity that receives benefits, such as financial resources, grants, or other assistance, typically as a result of an agreement or program. Beneficiaries can be individuals, organizations, businesses, or public institutions. In the context of EU or government programs, a beneficiary must meet specific criteria to be eligible for support.

Beneficiaries chart

Dystrogen Therapeutics
Krzysztof Siemionow
0.02 %
Maria Siemionow
0.02 %